scholarly journals POINT: In the Era of Cystic Fibrosis Transmembrane Regulator Protein Modulator Therapy, Are the Treatment Goals for Adults Now Different From Those for Children With Cystic Fibrosis? Yes

CHEST Journal ◽  
2022 ◽  
Vol 161 (1) ◽  
pp. 18-20 ◽  
Author(s):  
Damian G. Downey
2019 ◽  
Vol 13 (1) ◽  
Author(s):  
Giuseppe Bellisola ◽  
Sara Caldrer ◽  
Mariangela Cestelli‐Guidi ◽  
Gianfelice Cinque

2020 ◽  
pp. 4151-4165
Author(s):  
Andrew Bush ◽  
Caroline Elston

Cystic fibrosis (CF) is a recessively inherited disease caused by mutations in the cystic fibrosis gene, located on the long arm of chromosome 7, which codes for a membrane protein—the cystic fibrosis transmembrane regulator protein—that is a chloride channel. More than 2,000 CF mutations have been identified, with the Δ‎F508 mutation being the most common of around 200 mutations that definitely cause disease (70% of CF chromosomes in the European population). Birth incidence varies with country of origin from 1 in 2,000 to 1 in 100,000. The most popular hypothesis is that mutant cystic fibrosis transmembrane regulator protein fails to transport chloride ions normally, and there is secondary impairment of sodium, bicarbonate, and water transport.


Author(s):  
Andrew Bush ◽  
Caroline Elston

Cystic Fibrosis (CF) is a recessively inherited disease caused by mutations in the cystic fibrosis gene, located on the long arm of chromosome 7, which codes for a membrane protein—the cystic fibrosis transmembrane regulator protein (CFTR)—that is a chloride channel. Around 1300 CF mutations have been identified, with the ...


Gene ◽  
2013 ◽  
Vol 523 (2) ◽  
pp. 137-146 ◽  
Author(s):  
Aswathy Sebastian ◽  
Lavanya Rishishwar ◽  
Jianrong Wang ◽  
Karen F. Bernard ◽  
Andrew B. Conley ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document